Navigation Links
Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
Date:11/3/2008

MONTVALE, N.J., Nov. 3 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that its subsidiary, PLIVA - Lachema a.s., has received final approval from the U.S. Food and Drug Administration (FDA) for its generic version of Pfizer Inc.'s Camptosar(R) (irinotecan hydrochloride) Injection, 20 mg/mL, packaged in 40 mg/2 mL and 100 mg/5 mL vials. The Company plans to launch its product in the fourth quarter of 2008. Barr's U.S. generic injectable portfolio now totals nine products.

Barr's generic version of Camptosar injection will compete in a market that had total annual sales of approximately $353 million for the twelve months ended August 2008, based on IMS sales data.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27 proprietary products in the U.S. and approximately 1,025 products globally outside of the U.S. For more information, visit http://www.barrlabs.com.

Forward-Looking Statements

This communication contains "forward-looking statements" which represent the current expectations and beliefs of management of Barr Pharmaceuticals, Inc. (the "Company") concerning the proposed merger of the Company (the "merger") with Boron Acquisition Corp
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Pregis Announces Investor Conference Call to Review 2008 Third Quarter Financial Results
2. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
3. Insulet Announces Sponsorship of International Diabetes Federations World Diabetes Day Campaign
4. SXC Health Solutions announces PBM services agreement with Health Plan of San Mateo
5. Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
6. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter 2009 Financial Results
7. Hooper Holmes Announces Third Quarter Earnings Release Date and Conference Call Information
8. Chindex International, Inc. Announces Preliminary Second Quarter Results and Improved Revenue Outlook for Fiscal 2009
9. Chindex International, Inc. Announces Appearances at Additional November Conferences
10. JZZ Technologies, Inc. Announces 3rd Quarter Results Date
11. Konica Minolta Sensing Americas Announces the Launch of the CM-SA Skin Analysis Software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014 Saint Luke’s Mid America ... Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for implementing ... Heart Association/American College of Cardiology Foundation in their ... Get With The Guidelines–Heart Failure is a quality ... most up-to-date, research-based guidelines with the goal of ...
(Date:11/21/2014)... Reston, VA (PRWEB) November 21, 2014 ... Care App (ECA) is an all-in-one senior care coordination ... data on loved ones simple and intuitive for family ... adult day care centers). Now, the family caregiver or ... track their daily activities, health data, medical records, goals, ...
(Date:11/21/2014)... Recently, DressVe.com , a renowned women’s dress wholesaler and ... of fashion accessories. Furthermore, the company has launched its Special ... on all its fashion items. Also, orders above $59 are ... the company, their wedding dresses and prom dresses are very ... discounted rates. , The CEO says “We are glad ...
(Date:11/21/2014)... York, NY (PRWEB) November 21, 2014 ... burden for its intended parents — and at the same ... a renewed sense of optimism for future parents across the ... success. , Prospective parents today are zoning in on ... However, beyond the encumbering costs, are individuals over-stressing clinical ...
(Date:11/21/2014)... DC; London, UK (PRWEB) November 21, 2014 ... the world’s only ISO verified healthcare professional panel, today announced ... growth: the appointment of Roni DasGupta as President of Market ... Director of Market Research, Europe. , Ms. DasGupta ... Senior Vice President and most recently Head of Sales. ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Comprehensive Senior Care Application Launched on Apple App Store 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2
... a new vaccine against childhood pneumonia, meningitis and ear ... Meanwhile, doctors are directing the supplies they do have ... such as those with sickle cell anemia, the AIDS ... ,PREVNAR fights the bacterium streptococcus pneumoniae, the leading ...
... in France, despite a diet rich in butter and other ... red wine, another staple of the French diet. //Scientists say ... explanation is pigments known as polyphenols. ,Polyphenols ... of the arteries. Polyphenols in red wine decreases the amount ...
... to a new study, there is no significant difference ... serotonin reuptake inhibitors (SSRIs) are now very widely used ... a brain chemical called serotonin that plays an important ... how individual SSRIs compare with one another. However, a ...
... A team of UK scientists has found six genes which ... that eventually, doctors will be able to gauge an individual ... genetic makeup.Only a small proportion of breast cancer cases are ... ,Two genes have already been firmly linked with some ...
... a new study alcoholics are prone to a kind of ... the study of alcohol on the health of aged people ... of persistent problem drinking were 20 per cent more likely ... Heavy drinkers ran a 10 per cent greater risk. These ...
... it thins the blood and prevents the clots that ... class of pain relievers known as nonsteroidal anti-inflammatory drugs.// ... and pains. The popular pain reliever ibuprofen blocks the ... sounds a warning for people who take both medicines. ...
Cached Medicine News:
(Date:11/18/2014)... Investor-Edge has initiated coverage on the ... Corporation (NASDAQ: GERN ), Tekmira Pharmaceuticals Corporation (NASDAQ: ... GALE ), and XOMA Corporation (NASDAQ: XOMA ). ... http://investor-edge.com/register . The US markets on Monday, ... Dow Jones Industrial Average finished at 17,647.75, up 0.07% and ...
(Date:11/18/2014)... Nov. 18, 2014 BioLink 2015, the ... Transfer Summit, co-organized by CCCMHPIE ( China Chamber ... Medicines & Health Products), UBM Live and Beijing ... 23rd, 2015 at Beijing Yizhuang Biomedical Park. ... This event will gather 200+ decision ...
(Date:11/18/2014)...   Rio Grande Valley Health Information Exchange (RGV ... Health Science Center at Houston (UTHealth)  School of Public ... selected Wellcentive,s suite of population health management solutions and ... to partner with hospitals and clinics in the region ... uninsured patient populations, initially focusing on the care of ...
Breaking Medicine Technology:Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 2Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 3Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 4Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA 5BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: